MICHELE HARRELL: Open Payments
NPI 1710685581 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $346 |
| Teva Pharmaceuticals USA, Inc. | 2 | $213 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $103 |
Products named: CAPLYTA, UZEDY, Auvelity, VRAYLAR.
Industry payments across MD — which companies pay providers there.
